SCHEMBL7036632

SCHEMBL7036632

Cc1ccccc1C(=NO)c1ccc(Nc2cccc3cnccc23)cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 10/20 0.47
MAPK13 O15264 9/20 0.47
MAPK12 P53778 9/20 0.47
MAPK11 Q15759 9/20 0.47
TRPV1 Q8NER1 1/20 0.46
ALDH1A1 P00352 8/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
MAPT P10636 6/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.44
KDM4E B2RXH2 5/20 0.42
LMNA P02545 2/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
KDR P35968 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7035666 0.89 MAPK14 (0.47) MAPK14MAPK13MAPK12MAPK11TRPV1
SCHEMBL7039905 0.86 ALDH1A1 (0.52) MAPK14MAPK13MAPK12MAPK11TRPV1
SCHEMBL7039290 0.86 MAPK14 (0.67) MAPK14MAPK13MAPK12MAPK11TRPV1
SCHEMBL7036392 0.86 MAPK14 (0.53) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7081239 0.83 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7081236 0.83 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11KMT2A
SCHEMBL7033510 0.82 MAPK14 (0.49) MAPK14MAPK13MAPK12MAPK11SMN1; SMN2
SCHEMBL5173645 0.82 MAPK14 (0.68) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7035645 0.81 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL1906645 0.81 MAPK14 (0.60) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP claimed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US claimed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US claimed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO claimed
EP-1289958-A2 BENZOPHENONES AS INHIBITORS OF IL-1$g(b) AND TNF-$g(a) Leo Pharma A/S (DK) 2003-03-12 EP disclosed
US-6432962-B2 Benzophenones as inhibitors of IL-1β and TNF-α LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-08-13 US disclosed
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2002-02-07 US disclosed
WO-2001090074-A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) LEO PHARMA A/S (DK) 2001-11-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020016347-A1 Benzophenones as inhibitors of IL-1beta and TNF-alpha IL1B, IL1A, NFKBIA MAPK14 625/4885MAPK13 1908/4885MAPK12 1184/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.